Testing LNK01001 for active ankylosing spondylitis
Part of Bones, joints & muscles clinical trials.
This trial tests a new oral medication called LNK01001 for adults with active ankylosing spondylitis. It aims to reduce pain, stiffness, and inflammation when standard NSAID treatments no longer help.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with ankylosing spondylitis (a type of arthritis that causes back pain and stiffness).
- Your back pain and other symptoms must be at least moderate (score of 4 or higher on a 0-10 scale).
- You have tried at least two different NSAIDs (anti-inflammatory pain relievers like ibuprofen) but they didn't work well, or you couldn't take them.
- Your spine cannot be completely fused (total spinal ankylosis).
- You must not be allergic to the study drug ingredients.
- You cannot be pregnant, nursing, or planning a pregnancy during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medication (called 608) for adults with active ankylosing spondylitis (AS). It aims to see if the drug can reduce AS symptoms and improve quality of life.
This trial tests a Chinese herbal tablet called Jitongning against a placebo to see if it can improve overall symptoms in people with active axial osteoarthritis. You may be eligible if your arthritis is active, you have a specific genetic marker (HLA-B27 positive), and your inflammation levels are high.
This trial is for people with ankylosing spondylitis (a type of arthritis that affects the spine) who are otherwise healthy. It may test a treatment to see if it helps control symptoms, whether your disease is active or stable.
This study tests whether combining two types of immune-blocking drugs (an IL-17 inhibitor and a TNF inhibitor) works better than either alone for treating ankylosing spondylitis. It is for people whose symptoms are not well controlled with NSAIDs.
This trial tests whether stem cells from donated bone marrow can reduce inflammation and pain in ankylosing spondylitis, a condition that causes the spine to become stiff and inflamed. Researchers will monitor how safe and effective this treatment is for eligible patients.
This trial tests a new acupuncture-based procedure called acupotomy to help people with ankylosing spondylitis (a condition that causes spine stiffness and pain). The study aims to see if this improved technique reduces pain and improves mobility.
Hear when a new Ankylosing Spondylitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.